Zacks Research Has Bearish Estimate for Teleflex Q4 Earnings

Teleflex Incorporated (NYSE:TFX) – Equities researchers at Zacks Research dropped their Q4 2024 EPS estimates for shares of Teleflex in a note issued to investors on Wednesday, January 8th. Zacks Research analyst R. Department now forecasts that the medical technology company will earn $3.83 per share for the quarter, down from their prior forecast of $3.85. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex’s Q2 2025 earnings at $3.71 EPS, Q3 2025 earnings at $3.75 EPS, Q4 2025 earnings at $4.18 EPS, FY2025 earnings at $15.16 EPS, Q4 2026 earnings at $4.16 EPS and FY2026 earnings at $16.59 EPS.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, topping analysts’ consensus estimates of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $764.40 million for the quarter, compared to analysts’ expectations of $768.68 million. During the same quarter in the prior year, the company earned $3.64 earnings per share. The business’s revenue was up 2.4% compared to the same quarter last year.

A number of other equities research analysts have also recently commented on the company. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Mizuho reduced their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Truist Financial decreased their price objective on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Finally, Royal Bank of Canada cut their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Stock Performance

Teleflex stock opened at $177.87 on Friday. The stock’s 50 day moving average is $187.06 and its 200 day moving average is $216.52. The company has a market capitalization of $8.26 billion, a P/E ratio of 35.36, a PEG ratio of 1.84 and a beta of 1.16. Teleflex has a twelve month low of $171.69 and a twelve month high of $256.85. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Friday, November 15th were given a dividend of $0.34 per share. The ex-dividend date was Friday, November 15th. This represents a $1.36 annualized dividend and a yield of 0.76%. Teleflex’s dividend payout ratio (DPR) is presently 27.04%.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Cromwell Holdings LLC boosted its stake in shares of Teleflex by 59.0% in the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after acquiring an additional 49 shares during the period. Avior Wealth Management LLC increased its holdings in Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after acquiring an additional 101 shares during the last quarter. Ashton Thomas Securities LLC bought a new position in shares of Teleflex during the 3rd quarter valued at about $40,000. True Wealth Design LLC increased its holdings in shares of Teleflex by 16,600.0% in the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock worth $41,000 after purchasing an additional 166 shares during the last quarter. Finally, Canada Pension Plan Investment Board purchased a new stake in shares of Teleflex in the second quarter worth about $42,000. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.